Complete Safety, Dosage & Side Effect Guide

What Is Bravecto and Why Do Vets Recommend It?

Bravecto is the brand name for fluralaner, an oral or topical isoxazoline-class parasiticide manufactured by Merck Animal Health. Since its FDA approval in 2014, Bravecto flea medicine for dogs has become one of the most widely prescribed long-duration ectoparasite preventives in the United States — and for good reason. A single dose provides up to 12 weeks of continuous protection against fleas (Ctenocephalides felis) and multiple tick species, which dramatically reduces the compliance burden that plagues monthly preventives.

What sets Bravecto apart from competitors like NexGard (afoxolaner, 30-day duration) or Simparica (sarolaner, 35-day duration) is its extended half-life. Fluralaner's elimination half-life in dogs is approximately 12-15 days, but its pharmacokinetic profile maintains therapeutic plasma concentrations well beyond what monthly products achieve at their trough levels. This means your dog maintains steady-state protection even if you're a few days late on the next dose — a practical advantage for busy households.

How Does Bravecto Work? Mechanism of Action Explained

Fluralaner works systemically. After your dog ingests the chewable tablet, the drug is absorbed into the bloodstream and distributes throughout the body. When a flea or tick bites your dog and ingests blood containing fluralaner, the compound binds to gamma-aminobutyric acid (GABA)-gated chloride channels and glutamate-gated chloride channels in the parasite's central nervous system.

This binding is non-competitive and irreversible at therapeutic concentrations. It causes uncontrolled neuronal hyperexcitation in the parasite, leading to paralysis and death. Fleas typically begin dying within 2 hours of administration, with >99% efficacy achieved within 8 hours. Ticks (including Ixodes scapularis, Rhipicephalus sanguineus, and Dermacentor variabilis) are killed within 12-48 hours depending on species.

Critically, fluralaner has selective toxicity — it binds far more strongly to invertebrate chloride channels than to mammalian ones. This selectivity is what gives isoxazolines their wide safety margin in dogs. However, as we'll discuss in the side effects section, this selectivity is not absolute, which is why some dogs experience neurological adverse events.

FDA-Approved Uses and Common Off-Label Applications

The FDA has approved Bravecto for the following indications in dogs:

• Flea treatment and prevention (Ctenocephalides felis) — kills adult fleas and prevents egg laying for 12 weeks
• Tick treatment and control — effective against black-legged tick (Ixodes scapularis), American dog tick (Dermacentor variabilis), brown dog tick (Rhipicephalus sanguineus), and lone star tick (Amblyomma americanum) for 8-12 weeks depending on species
• Treatment and control of sarcoptic mange (Sarcoptes scabiei) — single dose effective
• Treatment and control of demodectic mange (Demodex canis) — single dose effective

Off-label uses your veterinarian may discuss include:

• Adjunctive treatment in flea allergy dermatitis (FAD) management protocols
• Off-label use against certain mite species not on the label (e.g., Cheyletiella, ear mites) — though evidence is more limited
• Part of a multimodal Lyme disease prevention strategy in endemic regions (combined with vaccination and tick checks)

Bravecto does NOT protect against heartworm, intestinal parasites, or mosquitoes. Your vet will likely recommend pairing it with a separate heartworm preventive such as Heartgard Plus or Interceptor Plus.

Bravecto Dosage by Weight: What Your Vet Will Prescribe

Bravecto chewable tablets come in pre-dosed strengths matched to weight bands. The target dosage is 25-56 mg fluralaner per kg of body weight (approximately 11.3-25.4 mg/lb), administered orally as a single dose every 12 weeks (84 days).

Administration instructions: Bravecto chewable tablets should be given with or around the time of feeding. Food significantly enhances the absorption of fluralaner — studies show bioavailability increases approximately 2.5-fold when administered with food compared to fasting. This is not optional; giving Bravecto on an empty stomach may result in sub-therapeutic plasma levels and reduced efficacy.

The topical formulation (Bravecto Topical Solution) is applied to the skin between the shoulder blades and along the back in a line, parting the fur to expose skin. Do not bathe your dog for 48 hours before or after topical application.

Duration of therapy: For flea and tick prevention, Bravecto is intended as a year-round, ongoing preventive. There is no defined endpoint — you continue administration for your dog's lifetime as part of routine wellness care. For sarcoptic or demodectic mange treatment, a single dose is typically curative, though your vet may recommend a second dose at 12 weeks for severe demodicosis cases.

Side Effects: What to Watch For

Bravecto is generally well-tolerated, with the majority of adverse events being mild and self-limiting. However, as with all isoxazoline-class drugs, there are neurological side effects that owners should understand.

The Isoxazoline and Seizure Connection

In September 2018, the FDA issued an advisory about isoxazoline-class drugs (including Bravecto, NexGard, Simparica, and Credelio) and their potential to cause adverse neurological events, including muscle tremors, ataxia, and seizures. The FDA noted that seizures have been reported in dogs with and without pre-existing seizure disorders.

The reported incidence of seizures with Bravecto is extremely low — well under 0.1% based on post-marketing surveillance data. However, because fluralaner's mechanism involves GABA receptor interaction (the same neurotransmitter system implicated in seizure threshold regulation), dogs with idiopathic epilepsy or a history of seizures should use Bravecto only after careful risk-benefit discussion with their veterinarian. Some veterinary neurologists prefer alternative drug classes (such as spinosad-based Comfortis or topical selamectin/Revolution) for known epileptic dogs.

Contraindications: Dogs Who Should Not Receive Bravecto

Bravecto carries specific contraindications and cautions that your vet will evaluate before prescribing:

• Puppies under 6 months of age: Bravecto is not approved for puppies younger than 6 months. The safety profile in very young dogs has not been fully established.
• Dogs under 4.4 lb (2 kg): The minimum weight for the lowest-dose chewable is 4.4 lb.
• Dogs with known hypersensitivity to fluralaner: Any prior allergic reaction to Bravecto or other isoxazolines precludes future use.
• Dogs with pre-existing seizure disorders (caution): Not an absolute contraindication, but the FDA advisory and pharmacological mechanism warrant careful consideration. Your vet may choose an alternative class.
• Bravecto Topical Solution — dogs under 8 weeks of age or under 4.4 lb: The topical formulation has slightly different minimum age/weight thresholds.

Pregnant, breeding, and lactating dogs: Bravecto has been evaluated in breeding, pregnant, and lactating dogs and was found to be safe at up to 3× the recommended dose. This is a notable advantage over some older parasiticide classes. However, your vet should still be aware of your dog's reproductive status.

Drug Interactions to Discuss With Your Veterinarian

Fluralaner is metabolized primarily by hepatic cytochrome P450 enzymes and is a substrate for P-glycoprotein (P-gp) transport. This creates potential for interactions with other drugs that share these metabolic pathways.

Always provide your veterinarian with a complete list of all medications, supplements, and over-the-counter products your dog is currently receiving. This includes flea collars, topical sprays, and any herbal remedies.

Monitoring, Missed Doses, and Overdose Protocol

Monitoring Requirements

Bravecto does not require routine blood work or laboratory monitoring in healthy dogs. Unlike some systemic medications (such as NSAIDs or phenobarbital), fluralaner does not typically affect liver enzymes, kidney values, or complete blood count parameters at labeled doses.

Your vet may recommend:

• Baseline wellness exam before starting any new long-term preventive — particularly to assess weight accurately for proper dosing
• Neurological monitoring for dogs with seizure history — observe closely for 48-72 hours after each dose
• Re-weighing at each dose interval — puppies and growing dogs may move up a weight band between 12-week doses, requiring a tablet strength adjustment
• Skin checks if using Bravecto as part of a mange treatment protocol — your vet will want to confirm mite clearance via skin scraping at follow-up

What to Do If You Miss a Dose

Because Bravecto's 12-week dosing interval provides a built-in buffer, a missed dose is less critical than with monthly products. However, the protocol is straightforward:

1. If you're 1-14 days late: Administer the missed dose as soon as you remember, then reset the 12-week schedule from that new date. Efficacy may be slightly reduced during the gap but therapeutic levels are often still present.
2. If you're more than 2 weeks late: Administer immediately and perform thorough tick checks daily until the next dose reaches full efficacy (approximately 48 hours post-administration). Consider a fast-acting adulticide (such as Capstar/nitenpyram) for immediate flea kill during the gap.
3. Never double-dose to compensate for a missed administration. Give a single standard dose and restart the schedule.

Overdose Protocol

In safety studies, Bravecto was administered to dogs at up to 5× the recommended dose (up to 5 times at 8-week intervals) without serious adverse effects. The margin of safety is wide. However, if your dog accidentally ingests multiple tablets or a dose intended for a much larger dog:

1. Remove access to any remaining medication
2. Note the exact amount ingested and time of ingestion
3. Contact your veterinarian or an emergency veterinary clinic
4. Call ASPCA Animal Poison Control: (888) 426-4435 for guidance
5. Monitor for vomiting, tremors, ataxia, or seizures — if any neurological signs appear, seek emergency care immediately

Cost Breakdown and Generic Availability (2026 Pricing)

Bravecto is a branded product manufactured exclusively by Merck Animal Health. As of 2026, no FDA-approved generic fluralaner product is available for dogs in the United States, though international generics exist in some markets (e.g., Fluraxx in parts of Europe). This exclusivity keeps pricing relatively stable but at a premium compared to some monthly alternatives.

Cost-saving tips: Many veterinary clinics offer Bravecto as part of annual wellness plans that bundle preventives at a discount. Chewy Pharmacy and 1Vet (online veterinary pharmacies accredited by the National Association of Boards of Pharmacy) often price 5-15% below in-clinic retail. Always verify that any online pharmacy requires a valid prescription — sites that sell Bravecto without one are operating illegally and may distribute counterfeit product.

Bravecto vs. Alternatives: Which Parasiticide Fits Your Dog?

Bravecto isn't the only option. Here's how it compares to the most commonly prescribed alternatives across key decision factors:

Non-isoxazoline alternatives your vet may consider for dogs with seizure histories or isoxazoline sensitivities include:

• Topical fipronil/(S)-methoprene (Frontline Plus): Non-systemic, applied to skin. Widely available OTC. Does not require prescription. Less effective in high-flea-burden environments and against certain tick species.
• Topical selamectin (Revolution): Prescription topical that also covers heartworm, ear mites, and sarcoptic mange. Lower flea kill speed than oral isoxazolines.
• Spinosad (Comfortis): Oral flea-only product (no tick coverage). 30-day duration. Different drug class — no GABA interaction. Not suitable for dogs on high-dose ivermectin.
• Fluralaner topical (Bravecto Topical Solution): Same active ingredient but applied to skin. Absorption profile differs — may be preferred by some owners who want to avoid oral administration, though systemic absorption still occurs.

Frequently Asked Questions About Bravecto

This guide is intended for informational purposes only and does not replace professional veterinary advice. Always consult your veterinarian for diagnosis, treatment, and medication decisions specific to your dog's health. Drug information is based on FDA-approved labeling and the Merck Veterinary Manual as of 2026. Individual responses to medication may vary.